Switch theme
Sign up to access all valuation multiples
Shionogi & Co Ltd is a specialty and generic drug manufacturing company. The company focuses on the manufacturing and distribution of pharmaceuticals, diagnostic reagents, and medical devices. Shionogi engages in manufacturing, formulation, packaging, and analysis as part of its commercialization research that spans late stage drug discovery through commercial production. The company's research and development strategy utilizes partnership and licensing opportunities with academic constituents and venture companies.
1919
6.3K+
LTM Revenue $3.0B
LTM EBITDA $1.2B
$8.8B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Shionogi has a last 12-month revenue of $3.0B and a last 12-month EBITDA of $1.2B.
In the most recent fiscal year, Shionogi achieved revenue of $2.9B and an EBITDA of $1.5B.
Shionogi expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Shionogi valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $2.8B | $2.9B | XXX | XXX | XXX |
| Gross Profit | $1.9B | $2.4B | XXX | XXX | XXX |
| Gross Margin | 66% | 84% | XXX | XXX | XXX |
| EBITDA | $1.6B | $1.5B | XXX | XXX | XXX |
| EBITDA Margin | 57% | 51% | XXX | XXX | XXX |
| Net Profit | $759M | $1.2B | XXX | XXX | XXX |
| Net Margin | 27% | 43% | XXX | XXX | XXX |
| Net Debt | n/a | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, Shionogi's stock price is JPY 2230 (or $15).
Shionogi has current market cap of JPY 1.90T (or $12.6B), and EV of JPY 1.33T (or $8.8B).
See Shionogi trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $8.8B | $12.6B | XXX | XXX | XXX | XXX | $1.34 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, Shionogi has market cap of $12.6B and EV of $8.8B.
Shionogi's trades at 2.9x LTM EV/Revenue multiple, and 7.1x LTM EBITDA.
Analysts estimate Shionogi's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Shionogi and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $8.8B | XXX | XXX | XXX |
| EV/Revenue | 3.0x | XXX | XXX | XXX |
| EV/EBITDA | 6.8x | XXX | XXX | XXX |
| P/E | 11.3x | XXX | XXX | XXX |
| P/E/Growth | 19.2x | XXX | XXX | XXX |
| EV/FCF | 8.2x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpShionogi's NTM/LTM revenue growth is 2%
Shionogi's revenue per employee for the last fiscal year averaged $0.5M, while opex per employee averaged $0.2M for the same period.
Over next 12 months, Shionogi's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Shionogi's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Shionogi and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | 2% | XXX | XXX | XXX | XXX |
| EBITDA Margin | 44% | XXX | XXX | XXX | XXX |
| EBITDA Growth | -8% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | 46% | XXX | XXX | XXX | XXX |
| Revenue per Employee | $0.5M | XXX | XXX | XXX | XXX |
| Opex per Employee | $0.2M | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | 23% | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | 24% | XXX | XXX | XXX | XXX |
| Opex to Revenue | 52% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Julphar | XXX | XXX | XXX | XXX | XXX | XXX |
| Galapagos | XXX | XXX | XXX | XXX | XXX | XXX |
| Pharming | XXX | XXX | XXX | XXX | XXX | XXX |
| Vivoryon Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| Armata Pharmaceuticals | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Shionogi acquired XXX companies to date.
Last acquisition by Shionogi was XXXXXXXX, XXXXX XXXXX XXXXXX . Shionogi acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was Shionogi founded? | Shionogi was founded in 1919. |
| Where is Shionogi headquartered? | Shionogi is headquartered in Japan. |
| How many employees does Shionogi have? | As of today, Shionogi has 6.3K+ employees. |
| Who is the CEO of Shionogi? | Shionogi's CEO is Dr. Isao Teshirogi, PhD. |
| Is Shionogi publicy listed? | Yes, Shionogi is a public company listed on TKS. |
| What is the stock symbol of Shionogi? | Shionogi trades under 4507 ticker. |
| When did Shionogi go public? | Shionogi went public in 1949. |
| Who are competitors of Shionogi? | Similar companies to Shionogi include e.g. Julphar, Galapagos, Pharming, Vivoryon Therapeutics. |
| What is the current market cap of Shionogi? | Shionogi's current market cap is $12.6B |
| What is the current revenue of Shionogi? | Shionogi's last 12-month revenue is $3.0B. |
| What is the current EBITDA of Shionogi? | Shionogi's last 12-month EBITDA is $1.2B. |
| What is the current EV/Revenue multiple of Shionogi? | Current revenue multiple of Shionogi is 2.9x. |
| What is the current EV/EBITDA multiple of Shionogi? | Current EBITDA multiple of Shionogi is 7.1x. |
| What is the current revenue growth of Shionogi? | Shionogi revenue growth between 2023 and 2024 was 2%. |
| Is Shionogi profitable? | Yes, Shionogi is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
